2:08 PM
 | 
Dec 01, 2017
 |  BC Week In Review  |  Company News  |  Deals

Nightstar gets rights to Stargardt gene therapy program

The University of Oxford and its research commercialization arm Oxford University Innovation (OUI) granted...

Read the full 47 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >